$AZN

$181.41▲ +4.0% YTD

5 SEC 13D/G filings tracked · Last updated Oct 30, 2026

Filing History

CP $181.41▲ +4.0%Oct 30, 2026 · ThinkSabio Blog

$AZN is launching a restructuring plan expected to generate $1.5B in annual savings, with up to $2B in one-time costs over the next three years. The c…

News

AZN ▼ -0.6% - AstraZeneca PLC

CP $171.49▲ -0.6%Oct 24, 2026 · ThinkSabio Blog

$AZN AstraZeneca: Phase 3 IMFINZI + Enfortumab Vedotin Cuts Death Risk by 42% and Event Risk by 49% in Muscle-Invasive Bladder Cancer ? • Overall Surv…

News

AZN ▼ -0.7% - AstraZeneca PLC

CP $155.80▲ -0.7%Oct 5, 2026 · ThinkSabio Blog

$AZN INVESTS $1 BLN TO GROW MASSACHUSETTS WORKFORCE BY OVER 50%…

News

AZN ▼ -1.3% - AstraZeneca PLC

CP $162.48▲ -1.3%Sep 4, 2026 · ThinkSabio Blog

$AZN - Talk FDA Grants Accelerated Approval to a New Breast Cancer Treatment (SM Circulations)…

News

AZN ▼ -0.8% - AstraZeneca PLC

CP $160.99▲ -0.8%Sep 1, 2026 · ThinkSabio Blog

$AZN AstraZeneca completes global license agreement for oral EGFR inhibitor ZEGFROVY® (sunvozertinib) for lung cancer…